1-8 of 8
Luminita Rusen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Thrombin Generation and Bleeding Phenotype during Personalized Prophylaxis with Recombinant Human FVIII in Previously Treated Patients with Severe Hemophilia A

Yesim G. Dargaud, MDPhD, Robert Klamroth, Luminita Rusen, MD, Jerzy Windyga, MD, Johann Bichler, PhD, Sigurd Knaub, Claude Negrier, MD
Journal: Blood
Blood (2016) 128 (22): 1410.
https://doi.org/10.1182/blood.V128.22.1410.1410
Published: 2016
Journal Articles

Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A

Clinical Trials & Observations
Johnny Mahlangu, Kazimierz Kuliczkowski, Faraizah Abdul Karim, Oleksandra Stasyshyn, Marina V. Kosinova, Lynda Mae Lepatan, Aleksander Skotnicki, Lisa N. Boggio, Robert Klamroth, Johannes Oldenburg, Andrzej Hellmann, Elena Santagostino, Ross I. Baker, Kathelijn Fischer, Joan C. Gill, Stephanie P’Ng, Pratima Chowdary, Miguel A. Escobar, Claudia Djambas Khayat, Luminita Rusen, Debra Bensen-Kennedy, Nicole Blackman, Tharin Limsakun, Alex Veldman, Katie St. Ledger, Ingrid Pabinger, for the AFFINITY Investigators
Journal: Blood
Blood (2016) 128 (5): 630–637.
https://doi.org/10.1182/blood-2016-01-687434
Published: 2016
Includes: Supplemental data
Journal Articles

Personalized Prophylaxis with Human-Cl Recombinant FVIII in HA Patients

Robert Klamroth, Toshko Lissitchkov, MD, Luminita Rusen, Olaf Walter, MD MBA, Johann Bichler, PhD, K John Pasi, Andreas Tiede, MD PhD, Sigurd Knaub, PhD
Journal: Blood
Blood (2015) 126 (23): 547.
https://doi.org/10.1182/blood.V126.23.547.547
Published: 2015
Journal Articles

Pharmacokinetics, Efficacy and Safety Of a Recombinant Factor IX (BAX326) In Previously-Treated Pediatric Patients < 12 Years Of Age With Severe Or Moderately Severe Hemophilia B

Tomasz Urasinski, Oleksandra Stasyshyn, Tatiana Andreeva, Luminita Rusen, Farida Perina, MyungShin Oh, Miranda Chapman, Borislava G Pavlova, Wing Yen Wong, Brigitt E. Abbuehl
Journal: Blood
Blood (2013) 122 (21): 1118.
https://doi.org/10.1182/blood.V122.21.1118.1118
Published: 2013
Journal Articles

Pharmacokinetics, Efficacy and Safety of BAX326, a Novel Recombinant Factor IX: A Prospective, Controlled, Multicenter Study in Previously Treated Patients with Severe (FIX Level < 1%) or Moderately Severe (FIX Level ≤ 2%) Hemophilia B.

Jerzy Windyga, MD, PhD, Toshko Lissitchkov, MD, PhD, Oleksandra Stasyshyn, MD, Vasily Mamonov, MD, Luminita Rusen, MD, PhD, José Luis Lamas, MD, Myungshin Oh, PhD, Miranda Chapman, Sandor Fritsch, PhD, Borislava G Pavlova, PhD, Wing Yen Wong, MD, Brigitt E. Abbuehl, MD
Journal: Blood
Blood (2012) 120 (21): 2222.
https://doi.org/10.1182/blood.V120.21.2222.2222
Published: 2012
Journal Articles

BDDrFVIII [moroctocog alfa (AF-CC), Xyntha] for Surgical Hemostasis in Patients with Hemophilia A: Results from a Pivotal Study.

Jerzy Windyga, MD, PhD, Luminita Rusen, MD, PhD, Amanda C. O’Brien, Brooke Hayward, SM, Steven Arkin, MD, David A. Roth, MD
Journal: Blood
Blood (2008) 112 (11): 1229.
https://doi.org/10.1182/blood.V112.11.1229.1229
Published: 2008
Journal Articles

Efficacy and Safety of ReFacto AF for Surgical Hemostasis in Previously Treated Patients with Severe Hemophilia A.

Jerzy Windyga, MD, PhD, Luminita Rusen, MD, Mona El-Hashimy, MD, David A. Roth, MD, Steven Arkin, MD
Journal: Blood
Blood (2007) 110 (11): 3960.
https://doi.org/10.1182/blood.V110.11.3960.3960
Published: 2007
Journal Articles

Randomized, Prospective Clinical Trial of rFVIIa for Secondary Prophylaxis in Hemophilia Patients with Inhibitors.

Barbara A. Konkle, Liselotte S. Ebbesen, Ute Friedrich, Raul P. Bianco, Toshko Lissitchkov, Luminita Rusen, Margit A. Serban
Journal: Blood
Blood (2006) 108 (11): 766.
https://doi.org/10.1182/blood.V108.11.766.766
Published: 2006